OR-GUROBI-OPTIMIZATION
Gurobi Optimization, LLC, creator of the world’s fastest mathematical optimization solver, has launched a new program to help independent software vendors (ISVs) tackle customers’ increasingly complex business challenges and keep up with ever-evolving customer needs.
While 85% of Fortune 500 companies use mathematical optimization, smaller startups and scaleups in the tech world are catching on to the value an industry-leading solver like Gurobi can bring to their software solutions. In fact, 70% of top global tech companies now use Gurobi.
Gurobi wants to be more than just a supplier to the ISVs that utilize its mathematical optimization technology; it wants to be a partner. That is the motivation behind the new Gurobi Partner Accelerator Program.
The 36-month program aims to create joint value between Gurobi and solution providers by setting and achieving shared business, product, and revenue goals.
“It’s not just a supplier relationship. We see it as a partnership. We want to support these companies and go hand-in-hand with them. If they grow, we grow together,” explained Jan Schwarzkopf, Gurobi Account Manager - Europe Ecosystem.
The Gurobi Partner Accelerator Program
Gurobi is offering a partnership with companies in the final stages of developing a software solution that utilizes its optimization technology. Companies will receive ongoing technical support, which is a critical asset in these final development stages.
In addition to technical support, partner companies will receive business and marketing support to accelerate their product’s time to market and maximize sales once launched.
This program is not just for companies in the development stage, though. ISVs that utilize Gurobi for products already on the market will also be eligible. The program’s ongoing technical and business support is essential for any company that wants to enhance its product to stay ahead in the highly competitive software market.
Benefits of the Program
By participating in the program, ISVs will receive the following:
- Easy Access to Gurobi’s Technology - Solution partners will receive access to Gurobi’s best-in-class technology, including a product license based on their business needs.
- Ongoing Sales and Marketing Support - The program includes guidance on sales and marketing strategies. Gurobi will work hand-in-hand with partners to advise on the best way to market their product and maximize sales once launched.
- Quarterly Engagement for Business Strategy - Gurobi will meet at least quarterly with solution partners to assist with high-level business strategy. Partners will get expert guidance on formulating and executing business goals.
Who Should Consider This Program?
The Gurobi Partner Accelerator Program is not limited to ISVs currently using Gurobi’s technology for their software solutions. Companies using an open-source solver or competitive commercial solver are also encouraged to consider the program.
For those using either an open-source or commercial solver, Gurobi poses the following questions:
- Are you or your end customers satisfied with the current performance of your software application?
- Does your relationship with your current optimization technology supplier support your business growth?
If the answer to one or both of these questions is no, the Gurobi Partner Accelerator Program might be the solution.
The software industry is getting more competitive every year, and ISVs need to ensure their solutions use every advantage available. The Gurobi Partner Accelerator Program is an excellent opportunity to access leading optimization solver technology, as well as hands-on support from experts who want their partners to succeed with optimization.
To learn more about the program, please visit https://www.gurobi.com/gurobi-alliance/gurobi-partner-accelerator-program/.
About Gurobi Optimization
With Gurobi’s decision intelligence technology, you can make optimal business decisions in seconds. From workforce scheduling, portfolio management, and marketing optimization, to supply chain design, and everything in between, Gurobi identifies your optimal solution, out of trillions of possibilities.
As the leader in decision intelligence, Gurobi delivers easy-to-integrate, full-featured software and best-in-class support, with an industry-leading 98.5% customer satisfaction rating.
Founded in 2008, Gurobi has operations across the Americas, Europe, and Asia. Over 2,500 global customers across 40+ industries run on Gurobi, including SAP, Air France, and the National Football League, as well as half of the Fortune 10 and 70% of top global tech companies. For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005558/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Pilots to Profit: NTT DATA's 2026 Global AI Report Shows How Top Performers Turn AI Vision Into Value8.12.2025 14:00:00 CET | Press release
Study reveals how the top 15% of companies are 2.5x more likely to post >10% revenue growth and over 3x more likely to achieve ≥15% profit margins from AI deployments NTT DATA, a global leader in AI, digital business and IT services, today released the 2026 Global AI Report: A playbook for AI leaders. The playbook is based on the company’s new benchmark research and reveals how “AI leaders” are separating from competitors through strategy and execution. The analysis is based on a survey of 2,567 senior executives across 35 countries and 15 industries. Only 15% of participating organizations qualified as “AI leaders,” defined by clear AI strategies, mature operating models and focused execution. These leaders report significantly higher revenue growth and profit margins than other organizations. “AI accountability now belongs in the boardroom and demands an enterprise-wide agenda,” said Yutaka Sasaki, President and CEO, NTT DATA Group. “Our research shows that a small group of AI leader
AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies8.12.2025 14:00:00 CET | Press release
Thorium-228 (228Th) is the parent isotope and key starting material to produce the alpha-emitter Lead-212 (212Pb) The established capability to receive and process high-activity 228Th, provides a key competitive advantage in scaling up 212Pb production to support the rapid advancement of 212Pb-ADVC001 (ADVC001) clinical development and the expanding pipeline The received 228Th will be processed into sources for our proprietary generator and installed in production systems first in Australia and subsequently in the US, as part of the planned expansion AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced it has received the first delivery of high-activity 228Th, the parent isotope of 212Pb and a key starting material to produce the alpha-emitter 212Pb, used to manufacture ADVC001, the company’s lead asset, and other 212Pb-based radioligand therapies in the pipeline. This delivery marks a major milestone for the
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia8.12.2025 14:00:00 CET | Press release
Multiple long-term follow-up studies confirm BRUKINSA’s superior efficacy and favorable tolerability versus ibrutinib in relapsed or refractory CLLAdditional ASH data from investigational BTK degrader, BGB-16673, highlight potential first- and best-in-class activity with durable responses in heavily pretreated patients with CLL BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, reaffirms its position as the leader in chronic lymphocytic leukemia (CLL) innovation by showcasing the depth, quality, and momentum of its hematology portfolio at the 67th ASH Annual Meeting and Exposition in Orlando, Florida. The totality of BeOne’s ASH data reinforce BRUKINSA® (zanubrutinib) as the foundational Bruton’s tyrosine kinase inhibitor (BTKi) of choice. “At ASH 2025, we will present new data from across our CLL franchise, highlighting both the strength of BRUKINSA and the potential of BGB-16673,” said Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology,
Pink Changing Lives®: Mary Kay Builds 11th Preschool in Sri Lanka, Turning a Dream Into Thousands of New Beginnings8.12.2025 14:00:00 CET | Press release
Each year, Mary Kay supports causes that enrich millions of women’s lives globally, including access to education Mary Kay Inc., a global champion for women’s empowerment, is turning pink into purpose through its Pink Changing Lives® Program to raise awareness and funds to support life-changing programs advancing cancer research, support survivors of domestic violence, protect our planet’s most precious resources, and create opportunities that help women and their families thrive. Since 1996, the multi-faceted Pink Changing Lives® Program has donated over $230 million in monetary and in-kind donations to improve the lives of women and their families in communities around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208554750/en/ Mary Kay Inc., a global champion for women’s empowerment, is turning pink into purpose through its Pink Changing Lives® Program to raise awareness and funds to support life-changing p
IonQ Expands in EU With Slovakia’s First National Quantum Communication Network8.12.2025 13:05:00 CET | Press release
Partnering with the Slovak Academy of Sciences, IonQ bolsters national security and European quantum communications infrastructure IonQ (NYSE: IONQ), the world’s leading quantum company, through its subsidiary ID Quantique (IDQ), today announced the deployment of Slovakia’s first national quantum communication network. Developed in partnership with the Institute of Physics, Slovak Academy of Sciences (IPSAS), the new system features a resilient hybrid architecture designed to strengthen the country’s cybersecurity infrastructure and support Europe’s quantum digital programs. The Slovak Quantum Communication Infrastructure (skQCI) project represents a major milestone in Slovakia’s contribution to the European Quantum Communication Infrastructure (EuroQCI) initiative, which seeks to establish a secure quantum-resistant communication backbone covering all European Union (EU) member states and territories. By integrating quantum-safe technologies at a national scale, Slovakia will directly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom